Menu
1 min read · estimated
APPROVED USE
What FDA approved
For adults and children with recurrent locally advanced or metastatic Merkel cell carcinoma.
LAMPGEN ANALYSIS
Why it matters
The action converted the earlier accelerated Merkel cell carcinoma indication to traditional approval.
What research teams should watch
Maintain the conversion date separately from the initial approval and record the recurrent or metastatic setting.
PRIMARY RECORDS